#ICYMI: Dr. Jia Ruan led a phase 2 #ClinicalTrial exploring a way to make chemotherapy more effective for people with a subtype of peripheral T-cell #lymphoma. Learn more about this Weill Cornell Medicine scientific collaboration published in @BloodJournal. bit.ly/3q5UhhY

via @NYTOpinion nytimes.com/2023/06/16/opi…

Who Employs Your Doctor? Increasingly, a Private Equity Firm. - The New York Times nytimes.com/2023/07/10/ups…

July 20, 1969 is a date that represents a pinnacle of human achievement - the #Apollo11 Moon landing. And while it was certainly special, it was only part of a long and challenging effort that involved thousands of people working hard and doing their part, resulting in the

Wordle 817 2/6 🟩⬛🟨⬛🟨 🟩🟩🟩🟩🟩 WordleBot Skill 97/99 Luck 87/99

One of the questions I'm always asked is “If you could do anything at all, what would you do?” My answer: I’d cure cancer. It’s not just personal – it’s about what’s possible. That’s why we’re investing $240 million to accelerate new ways to prevent and treat cancer.

nytimes.com/2023/10/03/opi…

New Strategy Attacks Treatment-Resistant Lymphomas news.weill.cornell.edu/news/2023/11/n…

Dr. Leandro Cerchietti (Leandro Cerchietti) explains outcomes from Weill Cornell Medicine led pre-clinical #research looking at targeting the tumor microenvironment and the potential role of QPCTL enzyme inhibition to attack #lymphoma cells: bit.ly/46Swthm #ASH23

Data from new #research presented at #ASH23 identified genetic alterations in #cancer cells that can cause a reduced response to certain immunotherapies used for B-cell #lymphomas. Dr. Leandro Cerchietti (Leandro Cerchietti) explains these results: bit.ly/4a3OGv4

Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential New Therapeutic Approach for Diffuse Large B-Cell Lymphoma readmagazine.com/industries/bio… via zafar inamdar

via New York Times Opinion nytimes.com/2024/03/18/opi…

Our review article on the tumor microenvironment in B-cell lymphoma, part of a series collection, is available in Blood. Full access link authors.elsevier.com/a/1ioEY1UYwnATg @BloodJournal

V. Craig Jordan obituary: pharmacologist who revolutionized breast cancer treatments nature.com/articles/d4158…

Great collaborative effort for #lymphoma research led by Leandro Cerchietti and Christopher Flowers MD Anderson Cancer Center Michael Green, PhD Happy to participate and looking forward to the team advancing the field! news.weill.cornell.edu/news/2024/08/n…

A new $12.5 million NIH grant for lymphoma research is the result of a team collaboration led by Dr. Leandro Cerchietti (Leandro Cerchietti) in our #HemOnc division & Dr. Christopher Flowers of MD Anderson Cancer Center bit.ly/3YRARge. Weill Cornell Medicine Meyer Cancer Center WCM Lymphoma Weill Cornell Medicine

Welcome to being a PI

Congratulations to our 2024 medicine laureate Victor Ambros ✨ This morning he celebrated the news of his prize with his colleague and wife Rosalind Lee, who was also the first author on the 1993 'Cell' paper cited by the Nobel Committee. #NobelPrize

Meet Leandro Cerchietti, MD! 🔬🧬 We’re proud to support Dr. Cerchietti’s research to help the immune system fight aggressive blood cancers like diffuse large B-cell lymphoma (DLBCL) with innovative treatments. Learn more 👉 bit.ly/4dGPMgZ #lymsm

nytimes.com/2025/02/14/opi… via @NYTOpinion